Membership Overview

Q: My organization is currently a Tier 2 member. Are we able to change membership tiers to Tier 1 after joining?

Member organizations are allowed to change their tier of membership at any point in time. An organization that changes their membership tier is responsible for prorated dues for the remainder of the calendar year in order to serve as a Governing Board (Tier 1) member.

Q: How may sub-teams can my organization join with a Tier 2 membership?

Tier 2 membership enables your organization to join as many sub-teams of interest.

Q: What type of meetings are involved in the SC Consortium? Is there a working meeting cadence or annual gathering for the whole group?

Tier 1 members participate in bi-monthly Governing Board meetings, which is primarily held in virtual format with plans for occasional in-person meetings to discuss the strategic direction and ongoing activities of the Consortium. Sub-teams have standing meetings at their own cadence for routine check-ins. These check-in meetings ensure each sub-team is actively making progress towards their planned activities and engagements, which revolve around their respective sub-team problem statements.

Q: What type of access does Tier 2 membership gain with the Governing Board and the objectives as a Consortium?

Tier 2 members routinely interact with Tier 1 members in all sub-team activities, in which all Governing Board members are active participants of the Consortium’s sub-teams. Sub-team activities do not distinguish membership tier with regards to participation on sub-team activities and all sub-team members work in tandem towards making progress on research problem statements.

Q: What are some examples of sub-team activities and engagements conducted to support the overall mission of the SC Consortium?

In an effort, to advance the field of subcutaneous drug development and delivery, the Governing Board plans the strategic direction and research roadmap for sub-team activities at the beginning of each calendar year. Prior examples of sub-team activities that aim to address sub-team-specific problem statements include: landscape assessment, landscape monitoring, data synthesis, web scraping, scientific conference workshops, manuscript development and publication, quantitative and qualitative market research, etc.

Members of the Subcutaneous Drug Development and Delivery (SC) Consortium are a diverse set of stakeholders, who come from organizations varying in size and background. Organizations eligible for membership include: small and large biotech companies, non-profit organizations, academics, payers, and regulatory agencies.
The collective objective of members is to collaboratively advance the most pressing issues and opportunities in subcutaneous drug development and delivery in a precompetitive manner.

Membership Benefits

Diverse expertise to foster creative solutions in a precompetitive manner
Member-exclusive workshop events focused on key areas at prominent scientific conferences and programs
Opportunity to collaboratively work on sub-team engagements that advance specific fields in subcutaneous drug development and delivery (i.e. High-Dose/High-Volume, Immunogenicity, Bioavailability, Patient Preference and Experience, and Clinical Trial Strategy)
Professional Networking and strategic partnering opportunities across public and private sectors

Tiered Membership Structure

The Subcutaneous Drug Development and Delivery (SC) Consortium features a tiered membership structure, designed to promote participation tailored to the specific organization’s interest levels. The variety of membership options gives your company the flexibility to choose your level of engagement based on your technology interests and priorities.

Tier 1 member organizations are part of the Governing Board, which lead the strategic direction of the Consortium.
Tier 2 members take part in specific sub-teams and work towards sub-team specific problem statements.

Please find an overview of the membership structure in the table below.

Tier 1 – Governing Board Members

Membership Rights

Automatic/designated primary and supporting board seat
Full voting rights on Governing Board
Can lead sub-teams
Participation of as many members as wanted in any sub-teams

Annual Dues

$50,000 USD

Tier 2 – Sub-Team Collaborators

Membership Rights

Participation on any/all sub-teams and ability to influence direction of sub-team work
Must comply with all legal/membership obligations of the SC Consortium (IPR, anti-competitive policy, etc.)
Non-voting participation on the Board and Sub-Teams

Annual Dues

Industry

Company Revenue >$500M = $35,000 USD
Company Revenue < $500M = $15,000 USD

Non-Industry

Regulatory agencies, Payers, PAGs, and Academic Institutions = $1,000 USD

The Subcutaneous Drug Development and Delivery (SC) Consortium has no organization eligibility requirements – any type of organization can join as a Tier 1 or 2 Member.

Empower innovations, join us to shape the future of subcutaneous drug development together!

Frequently Asked Questions (FAQs)

What are the different sub-teams that are available for my organization to join?

The Subcutaneous Drug Development and Delivery (SC) Consortium, herein SC Consortium, currently comprises five sub-teams, each working towards their own problem statements and research goals within the field:

High-Dose/High-Volume
Patient Preference and Experience
Clinical Trial Strategy
Bioavailability
Immunogenicity
Sustainability

My organization is currently a Tier 2 member. Are we able to change membership tiers to Tier 1 after joining?

Member organizations are allowed to change their tier of membership at any point in time. An organization that changes their membership tier is responsible for prorated dues for the remainder of the calendar year in order to serve as a Governing Board (Tier 1) member.

How may sub-teams can my organization join with a Tier 2 membership?

Tier 2 membership enables your organization to join as many sub-teams of interest.

What type of meetings are involved in the SC Consortium? Is there a working meeting cadence or annual gathering for the whole group?

Tier 1 members participate in bi-monthly Governing Board meetings, which is primarily held in virtual format with plans for occasional in-person meetings to discuss the strategic direction and ongoing activities of the Consortium.

Sub-teams have standing meetings at their own cadence for routine check-ins. These check-in meetings ensure each sub-team is actively making progress towards their planned activities and engagements, which revolve around their respective sub-team problem statements.

What type of access does Tier 2 membership gain with the Governing Board and the objectives as a Consortium?

Tier 2 members routinely interact with Tier 1 members in all sub-team activities, in which all Governing Board members are active participants of the Consortium’s sub-teams. Sub-team activities do not distinguish membership tier with regards to participation on sub-team activities and all sub-team members work in tandem towards making progress on research problem statements.

What are some examples of sub-team activities and engagements conducted to support the overall mission of the SC Consortium?

In an effort, to advance the field of subcutaneous drug development and delivery, the Governing Board plans the strategic direction and research roadmap for sub-team activities at the beginning of each calendar year. Prior examples of sub-team activities that aim to address sub-team-specific problem statements include: landscape assessment, landscape monitoring, data synthesis, web scraping, scientific conference workshops, manuscript development and publication, quantitative and qualitative market research, etc.

Interested in learning more on how to join the Subcutaneous Development and Delivery Consortium?

Participating in the Consortium

The activities and efforts of the Subcutaneous Drug Development and Delivery Consortium provide an opportunity for participating organizations to proactively impact and drive value across SC drug development and delivery and ultimately provide value to the larger community.